Effect of furosemide on serum clearance and renal excretion of digoxin. 1979

E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima

Serum turnover and urinary excretion of digoxin with or without oral furosemide were studied in six healthy subjects who received 0.006 mg/kg body weight digoxin intravenously. During furosemide treatment, the total amount of urinary digoxin did not change but the digoxin clearance during the diuretic phase and the digoxin excretion after the diuresis decreased significantly. The average serum half-life was prolonged from 37 hours in the control period to 86 hours in the furosemide period. Decreased glomerular filtration rate by volume depletion might have been responsible for the decreased excretion of digoxin, but there was no significant difference in urine volume after diuresis between the two periods, suggesting the possibility of inhibition of tubular secretion of digoxin by furosemide. It is also possible that serum digoxin concentration may be elevated if furosemide were given more frequently.

UI MeSH Term Description Entries
D008297 Male Males
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005665 Furosemide A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. Frusemide,Fursemide,Errolon,Frusemid,Furanthril,Furantral,Furosemide Monohydrochloride,Furosemide Monosodium Salt,Fusid,Lasix
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
October 1976, Clinical pharmacology and therapeutics,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
January 1976, Journal of clinical pharmacology,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
July 1984, Clinical pharmacology and therapeutics,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
October 1981, The Journal of pharmacology and experimental therapeutics,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
April 1981, Archivos de farmacologia y toxicologia,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
October 1984, Clinical pharmacology and therapeutics,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
September 1975, The New England journal of medicine,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
January 1985, Acta medica Scandinavica,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
January 1983, European journal of clinical pharmacology,
E Tsutsumi, and H Fujiki, and H Takeda, and H Fukushima
July 1982, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!